# MADRIGAL PHARMACEUTICALS INC (MDGL)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/MDGL/

- Reporting holders: 7
- Reported value: $756.9K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $434.4K | 862 | 0.0% | 10 |
| [CoreCap Advisors, LLC](https://holderbook.com/funds/1902501-corecap-advisors-llc/) | $141.1K | 280 | 0.0% | 9 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $140.6K | 279 | 0.0% | 12 |
| [EASTERN BANK](https://holderbook.com/funds/1126395-eastern-bank/) | $32.8K | 65 | 0.0% | 9 |
| [MassMutual Private Wealth & Trust, FSB](https://holderbook.com/funds/1103653-massmutual-private-wealth-trust-fsb/) | $5.0K | 10 | 0.0% | 10 |
| [TOTH FINANCIAL ADVISORY CORP](https://holderbook.com/funds/866780-toth-financial-advisory-corp/) | $1.5K | 3 | 0.0% | 4 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $1.5K | 3 | 0.0% | 1 |
| [CX Institutional](https://holderbook.com/funds/1737089-cx-institutional/) | $1 | 2 | 0.0% | 4 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 7 | $756.9K |
| Q2 2026 | 421 | $14.2B |
| Q1 2026 | 384 | $13.1B |
| Q4 2025 | 390 | $14.3B |
| Q3 2025 | 360 | $11.4B |
| Q2 2025 | 312 | $7.6B |
| Q1 2025 | 329 | $8.4B |
| Q4 2024 | 293 | $7.8B |
| Q3 2024 | 266 | $5.2B |
| Q2 2024 | 266 | $6.9B |
| Q1 2024 | 277 | $6.6B |
| Q4 2023 | 233 | $5.1B |